Nasus Pharma Ltd. (NSRX) — Financial Flexibility Index
Nasus Pharma Ltd. (NSRX) has a Financial Flexibility Index of -2.19x as of December 2025. Free cash flow of $-4.90 Million (operating CF $-4.92 Million minus capex $14.00K) represents -2% of total liabilities ($2.24 Million). Also explore Nasus Pharma Ltd. equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nasus Pharma Ltd. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Nasus Pharma Ltd. across 4 annual periods. Check NSRX cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Nasus Pharma Ltd. (2022–2025)
Year-by-year free cash flow to debt coverage for Nasus Pharma Ltd.. For the full company profile including market capitalisation, see Nasus Pharma Ltd. (NSRX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.19x | $-4.90 Million | $-4.92 Million | $2.24 Million | ▼ -1195.8% |
| 2024 | -0.17x | $-665.00K | $-665.00K | $3.93 Million | ▲ +30.2% |
| 2023 | -0.24x | $-1.03 Million | $-1.03 Million | $4.24 Million | ▲ +35.8% |
| 2022 | -0.38x | $-1.21 Million | $-1.21 Million | $3.20 Million | — |